A nationwide recall is underway for more than 11,000 bottles of a common blood pressure medication, the Food and Drug Administration (FDA) reported. The drugs—a generic version of Ziac—were initially recalled on Nov. 21 after sample testing found trace amounts of a cholesterol medication made by the same company, Glenmark Pharmaceuticals. On Dec. 1, the FDA gave the recall a Class III risk level, indicating a low risk of harm.
The recall impacts prescription 2.5-milligram/6.25-milligram bisoprolol fumarate and hydrochlorothiazide tablets in the following sizes and codes:
Size
National Drug Code (NDC)
Lot Codes
30-count
68462-878-30
Lot 17232401, exp 11/2025 and lot 17240974, exp 05/2026
100-count
68462-878-01
Lot 17232401, exp 11/2025 and lot 17240974, exp 05/2026
500-count
68462-878-05
Lot 17232401, exp 11/2025 and lot 17240974, exp 05/2026
The FDA did not provide specific instructions, but Class III recalls are unlikely to cause adverse health consequences, and stopping a medication could be riskier.
“While recall notifications can be frightening, it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine,” advised Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices. “Some medicines … should not be stopped suddenly.”
You can also contact Glenmark’s customer service center with any questions at GlobalCustomerService@glenmarkpharma.com or at 1-888-721-7115.
Health.com uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
